Up-regulation of interleukin-4 production via NF-AT/AP-1 activation in T cells by biochanin A, a phytoestrogen and its metabolites

Toxicol Appl Pharmacol. 2006 May 1;212(3):188-99. doi: 10.1016/j.taap.2005.08.001. Epub 2005 Sep 15.

Abstract

Phytoestrogens are naturally occurring compounds derived from plants. Although phytoestrogens exhibit many biological functions including estrogen agonist/antagonist properties, the effect on allergic responses remains unclear. In this study, we investigated whether biochanin A, a phytoestrogen and its metabolites, genistein, p-ethylphenol and phenolic acid, affect production of IL-4, a pro-inflammatory cytokine closely associated with allergic immune responses, in primary CD4(+) T cells and EL4 T lymphoma cells. Biochanin A, genistein and p-ethylphenol significantly enhanced IL-4 production from both CD4(+) T cells and EL4 cells in a dose-dependent manner, while phenolic acid did not. Biochanin A, genistein and p-ethylphenol also enhanced IL-4 gene promoter activity in EL4 cells transiently transfected with IL-4 promoter constructs, but this effect was impaired in EL4 cells transfected with an IL-4 promoter construct deleted of a P4 site carrying NF-AT and AP-1 binding sites. In addition, biochanin A, genistein and p-ethylphenol increased both NF-AT and AP-1 DNA binding activities, indicating that they might enhance IL-4 production via NF-AT/AP-1 activation. Furthermore, biochanin A, genistein and p-ethylphenol increased p38 MAPK phosphorylation and PKC activity, while they did not affect ERK phosphorylation. The enhanced NF-AT DNA binding activities were suppressed by inhibitors for PI3-K and PKC, but not by p38 MAPK inhibitors. In contrast, the enhanced AP-1 DNA binding activities and p38 MAPK phosphorylation were significantly suppressed by specific inhibitors for PKC and p38 MAPK, but not by PI3-K inhibitors. These results demonstrate, for the first time, that biochanin A, genistein and p-ethylphenol enhance IL-4 production in activated T cells by two independent pathways, PI3-K/PKC/NF-AT and PKC/p38 MAPK/AP-1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • CD4-Positive T-Lymphocytes / drug effects*
  • CD4-Positive T-Lymphocytes / immunology
  • CD4-Positive T-Lymphocytes / metabolism
  • Cell Line, Tumor
  • DNA / metabolism
  • DNA-Binding Proteins
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / pharmacology
  • Genistein / metabolism
  • Genistein / pharmacology*
  • Humans
  • Interleukin-4 / genetics
  • Interleukin-4 / metabolism*
  • Lymphocyte Activation / drug effects*
  • Lymphocyte Activation / immunology
  • Lymphoma / drug therapy
  • Lymphoma / metabolism
  • Lymphoma / pathology
  • NFATC Transcription Factors / genetics
  • NFATC Transcription Factors / metabolism*
  • Phenols / pharmacology
  • Phosphorylation
  • Phytoestrogens / pharmacology*
  • RNA, Messenger / metabolism
  • Transcription Factor AP-1 / genetics
  • Transcription Factor AP-1 / metabolism*
  • Transfection
  • Up-Regulation
  • p38 Mitogen-Activated Protein Kinases / metabolism

Substances

  • DNA-Binding Proteins
  • Enzyme Inhibitors
  • NFATC Transcription Factors
  • Phenols
  • Phytoestrogens
  • RNA, Messenger
  • Transcription Factor AP-1
  • Interleukin-4
  • DNA
  • 4-ethylphenol
  • Genistein
  • p38 Mitogen-Activated Protein Kinases
  • biochanin A